LEQEMBI Trademark

Trademark Overview

On Wednesday, December 1, 2021, a trademark application was filed for LEQEMBI with the United States Patent and Trademark Office. The USPTO has given the LEQEMBI trademark a serial number of 97151804. The federal status of this trademark filing is REGISTERED as of Tuesday, April 11, 2023. This trademark is owned by Eisai R&D Management Co., Ltd.. The LEQEMBI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of Alzheimer's disease and related disorders, cognitive impairment and dementia
leqembi

General Information

Serial Number97151804
Word MarkLEQEMBI
Filing DateWednesday, December 1, 2021
Status700 - REGISTERED
Status DateTuesday, April 11, 2023
Registration Number7027708
Registration DateTuesday, April 11, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 24, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment and prevention of Alzheimer's disease and related disorders, cognitive impairment and dementia
Translation of Words in MarkThe wording "LEQEMBI" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 6, 2021
Primary Code005
First Use Anywhere DateWednesday, January 18, 2023
First Use In Commerce DateWednesday, January 18, 2023

Trademark Owner History

Party NameEisai R&D Management Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTokyo 112-8088
JP
Party NameEisai R&D Management Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTokyo 112-8088
JP
Party NameEisai R&D Management Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTokyo 112-8088
JP

Trademark Events

Event DateEvent Description
Tuesday, April 11, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, April 11, 2023REGISTERED-PRINCIPAL REGISTER
Wednesday, March 8, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, March 7, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, March 7, 2023STATEMENT OF USE PROCESSING COMPLETE
Thursday, February 16, 2023USE AMENDMENT FILED
Monday, March 6, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, February 16, 2023TEAS STATEMENT OF USE RECEIVED
Saturday, September 10, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 8, 2022SOU EXTENSION 1 GRANTED
Thursday, September 8, 2022SOU EXTENSION 1 FILED
Thursday, September 8, 2022TEAS EXTENSION RECEIVED
Tuesday, July 19, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 24, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 24, 2022PUBLISHED FOR OPPOSITION
Wednesday, May 4, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 20, 2022LAW OFFICE PUBLICATION REVIEW COMPLETED
Sunday, April 17, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, April 16, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 15, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 15, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 22, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 22, 2022NON-FINAL ACTION E-MAILED
Tuesday, March 22, 2022NON-FINAL ACTION WRITTEN
Friday, March 18, 2022ASSIGNED TO EXAMINER
Monday, December 27, 2021PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Monday, December 27, 2021ASSIGNED TO LIE
Tuesday, December 21, 2021TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, December 6, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, December 4, 2021NEW APPLICATION ENTERED

Related Keywords

leqembi disorders cognitive impairment dementia related disease preparations treatment prevention alzheimer